Home / Countries / Israel / HIV medicines

Israel · availability and reimbursement

HIV medicines in Israel

Of 24 verified HIV medicine records for Israel, 22 are available and reimbursed (92%), 0 are available but not reimbursed and 2 are not available. 14 further records are still under review.

92% of verified records reimbursed

Last checked 14/09/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 22

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Odefsey, Pifeltro, Prezista, Rukobia, Sunlenca, Symtuza, Tivicay, Triumeq, Truvada, Vocabria

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 14

Apretude, Emtriva, Epivir, Eviplera, Kivexa, Norvir, Rekambys, Retrovir, Rezolsta, Stribild, Viread, Vocabria / Rekambys, Yeytuo, Ziagen

See every medicine with its source →

More about Israel

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Israel profile

Neighbouring countries

CyprusTurkeyArmeniaGreece

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.